Nasal Foralumab

foralumab · Tiziana Life Sciences Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nasal Foralumab, covering 2025-10-15 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients [Phase 2]